Melatonin supplementation improves glycemic hemostasis, lipid profile, and adipokine concentrations of obese women: A double-blind randomized clinical trial
Biomedicine Advances · 01.10.2024 · 1 (1) · 27-33
DOI: 10.34172/bma.05 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Biomedicine Advances, online erschienen am 01.10.2024. Verfasst von Naimeh Mesri Alamdari und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Obesity and related diseases are an important universal public issue that harms man’s well-being. Recently, growing attention has been paid to the anti-obesity effect of melatonin.
Objective
This study aims to assess melatonin’s impact on obesity-related factors including glycemic status, adipokines levels, lipid, and anthropometric indices in women who are obese and undergoing a calorie-restricted diet.
Methods
In this double-blind placebo-controlled randomized clinical trial (RCT) study, 46 obese women were randomly assigned into either melatonin (6 g/d) or placebo (6 g/d) group and calorie-restricted diets for 40 days. Serum concentrations of fasting blood sugar (FBS), insulin, leptin, adiponectin, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), triglycerides (TG), low-density lipoprotein cholesterol (LDL-c), insulin resistance as well as anthropometric indices were evaluated at the beginning and end of the intervention.
Findings
Melatonin consumption grave rise a marked diminish in insulin (P=0.006) and HOMA-IR (P=0.001), which the between-group comparisons were substantial only for HOMA-IR (P=0.020) after adjusting for confounders. Adiponectin levels improved remarkably relative to the placebo (P=0.010). Lipid measures including TG, LDL-c, and HDL-c declined remarkably in the melatonin group post-intervention, whereas among-group percent changes were notable in HDL-c after adjusting for confounders (P=0.040). Notable variations were not observed in anthropometric indices in the melatonin group, compared to the placebo at the final. Conclusion: the present study, revealed that melatonin supplementation markedly improved glycemic indices, adiponectin, and lipid profile related to obesity. Trial Registration: Identifier: IRCT2012122411867N1; https://irct.behdasht.gov.ir/.
Zitieren
APA
Alamdari, N. M., Shabestari, A. N., Najafipour, F., & Mirmazhari, A. (2024). Melatonin supplementation improves glycemic hemostasis, lipid profile, and adipokine concentrations of obese women: A double-blind randomized clinical trial. Biomedicine Advances, 1(1), 27-33. https://doi.org/10.34172/bma.05
Vancouver
Alamdari NM, Shabestari AN, Najafipour F, Mirmazhari A. Melatonin supplementation improves glycemic hemostasis, lipid profile, and adipokine concentrations of obese women: A double-blind randomized clinical trial. Biomedicine Advances. 2024;1(1):27-33. doi:10.34172/bma.05
BibTeX
@article{Alamdari2024,
author = {Alamdari, Naimeh Mesri and Shabestari, Arvin Namazi and Najafipour, Farzad and Mirmazhari, Amirali},
title = {Melatonin supplementation improves glycemic hemostasis, lipid profile, and adipokine concentrations of obese women: A double-blind randomized clinical trial},
journal = {Biomedicine Advances},
year = {2024},
volume = {1},
number = {1},
pages = {27--33},
doi = {10.34172/bma.05}
}
EUVIMED